125 related articles for article (PubMed ID: 8540313)
1. A minute gastric cancer detected by a new screening method using serum pepsinogen I and II.
Yahagi N; Miki K; Ichinose M; Kakei N; Matsushima M; Kido M; Shimizu Y; Ishihama S; Tsukada S; Kurokawa K
Adv Exp Med Biol; 1995; 362():145-8. PubMed ID: 8540313
[No Abstract] [Full Text] [Related]
2. Two cases of early colorectal cancer associated with gastric adenoma detected by serum pepsinogen screening method.
Shimizu Y; Kakei N; Wada T; Yahagi N; Kido M; Ishihama S; Tsukada S; Matsushima M; Ichinose M; Miki K
Adv Exp Med Biol; 1995; 362():149-54. PubMed ID: 8540314
[No Abstract] [Full Text] [Related]
3. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study.
Aoki K; Misumi J; Kimura T; Zhao W; Xie T
J Epidemiol; 1997 Sep; 7(3):143-51. PubMed ID: 9337512
[TBL] [Abstract][Full Text] [Related]
5. The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer.
Miki K; Ichinose M; Kakei N; Yahagi N; Matsushima M; Tsukada S; Ishihama S; Shimizu Y; Suzuki T; Kurokawa K
Adv Exp Med Biol; 1995; 362():139-43. PubMed ID: 8540312
[No Abstract] [Full Text] [Related]
6. [Evaluation on a gastric mass survey-comparison with gastric mass screening using photofluorography and that using serum pepsinogen].
Tomooka Y
Nihon Koshu Eisei Zasshi; 1996 Feb; 43(2):118-25. PubMed ID: 8901216
[No Abstract] [Full Text] [Related]
7. Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens.
Hattori Y; Tashiro H; Kawamoto T; Kodama Y
Jpn J Cancer Res; 1995 Dec; 86(12):1210-5. PubMed ID: 8636012
[TBL] [Abstract][Full Text] [Related]
8. [Mass screening of stomach neoplasms by serum pepsinogen analysis].
Miki K
Nihon Naika Gakkai Zasshi; 1992 May; 81(5):654-9. PubMed ID: 1512496
[No Abstract] [Full Text] [Related]
9. [Mass screening of gastric cancer--limits and prospects].
Yamaki G; Higashi K
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1883-7. PubMed ID: 12465385
[TBL] [Abstract][Full Text] [Related]
10. The association of smoking and drinking habits with serum pepsinogens.
Kikuchi S; Inaba Y; Wada O; Miki K; Tenjin H; Kaneko E; Mizukoshi H
Int J Epidemiol; 1995 Apr; 24(2):346-53. PubMed ID: 7635595
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions.
Hallissey MT; Dunn JA; Fielding JW
Scand J Gastroenterol; 1994 Dec; 29(12):1129-34. PubMed ID: 7886402
[TBL] [Abstract][Full Text] [Related]
12. Serum pepsinogen in screening for gastric cancer.
Kodoi A; Yoshihara M; Sumii K; Haruma K; Kajiyama G
J Gastroenterol; 1995 Aug; 30(4):452-60. PubMed ID: 7550854
[TBL] [Abstract][Full Text] [Related]
13. Serum pepsinogen and gastric cancer screening.
Mukoubayashi C; Yanaoka K; Ohata H; Arii K; Tamai H; Oka M; Ichinose M
Intern Med; 2007; 46(6):261-6. PubMed ID: 17379991
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the validity of three biomarkers for gastric cancer screening: carcinoembryonic antigen, pepsinogens, and high sensitive C-reactive protein.
Chung HW; Kim JW; Lee JH; Song SY; Chung JB; Kwon OH; Lim JB
J Clin Gastroenterol; 2009 Jan; 43(1):19-26. PubMed ID: 18648315
[TBL] [Abstract][Full Text] [Related]
15. Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults.
Kikuchi S; Wada O; Miki K; Nakajima T; Nishi T; Kobayashi O; Inaba Y
Cancer; 1994 Jun; 73(11):2695-702. PubMed ID: 8194008
[TBL] [Abstract][Full Text] [Related]
16. [Pepsinogen].
Miki K
Nihon Rinsho; 1995 May; 53(5):1198-202. PubMed ID: 7602778
[TBL] [Abstract][Full Text] [Related]
17. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Kitadai Y; Komoto K; Tanaka S; Kajiyama G
Am J Gastroenterol; 1998 Jul; 93(7):1090-6. PubMed ID: 9672336
[TBL] [Abstract][Full Text] [Related]
18. Serum pepsinogen I as a predictor of stomach cancer.
Nomura AM; Stemmermann GN; Samloff IM
Ann Intern Med; 1980 Oct; 93(4):537-40. PubMed ID: 7436185
[TBL] [Abstract][Full Text] [Related]
19. [Roles of pepsinogen test, ABC method and barium X-ray examination on gastric cancer screening].
Nakajima S
Nihon Shokakibyo Gakkai Zasshi; 2013 Feb; 110(2):225-33. PubMed ID: 23381210
[No Abstract] [Full Text] [Related]
20. [Evaluation of guideline for stomach cancer mass screening].
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1183-97. PubMed ID: 16955959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
